SIC 2833 – Medicinal Chemicals and Botanical Products
| Valuation | |
|---|---|
| Market Cap ($M) | 335.90 |
| Enterprise Value ($M) | n/a |
| Book Value ($M) | 1,100.20 |
| Book Value / Share | 4.28 |
| Price / Book | n/a |
| NCAV ($M) | 208.68 |
| NCAV / Share | 0.81 |
| Price / NCAV | n/a |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.09 |
| Return on Assets (ROA) | -0.07 |
| Return on Equity (ROE) | -0.09 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 3.12 |
| Current Ratio | 4.62 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 420.75 |
| Assets | 1,312.27 |
| Liabilities | 212.07 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 920.45 |
| Operating Income | -33.55 |
| Net Income | -94.80 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 54.91 |
| Cash from Investing | 17.76 |
| Cash from Financing | -49.36 |
(click for more detail) |
|
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 367,585 | 1,627,939 | 22.58 | |
| 255,811 | 1,329,829 | 19.24 | |
| 503,278 | 1,904,912 | 26.42 | |
| 419,318 | 1,805,117 | 23.23 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| SLGL – Sol-Gel Technologies Ltd. | SLRX – Salarius Pharmaceuticals, Inc. |
| SLS – SELLAS Life Sciences Group, Inc. | SNGX – Soligenix, Inc. |
| SNPX – Synaptogenix, Inc. |
Financial data and stock pages provided by
Fintel.io